Streetbeat News

Products Services

BDRX

Biodexa Pharmaceuticals has been granted U.S. Patent Number 12,011,445 for the prevention of pancreatic cell degeneration, aimed at treating Type I Diabetes. The patent is licensed from Melior Pharmaceuticals.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 2:58 pm

NGNE

Neurogene shares are trading lower after the company announced that the first patient in Cohort 2 received high-dose NGN-401 gene therapy in the Phase 1/2 trial for female pediatric patients with Rett syndrome.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 2:57 pm

IRTC

iRhythm Technologies shares are trading higher after the company announced a corporate milestone with the launch of the initial phases of its manufacturing automation plans.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 2:53 pm

BTCUSD

SPY

Jim Bianco from Bianco Research claims that most Bitcoin ETF buyers are retail investors, not institutional ones. This is evidenced by the small average trade size of $14,600. Retail investors are more likely to panic sell, potentially increasing market volatility. Recent trends show Bitcoin ETF outflows and falling prices, with the next significant event being the FOMC meeting on July 31.

Portfolio Pulse from Khyathi Dalal

June 18, 2024 | 2:49 pm

GLW

Corning Incorporated (NYSE:GLW) has announced a collaboration with the National Institute for Bioprocessing Research and Training (NIBRT) to integrate its Ascent® Fixed Bed Bioreactor System into NIBRT's training programs. This partnership aims to accelerate cell therapy development and expand Corning's presence in the European life sciences market.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 2:48 pm

BIDU

Investors have taken a bullish stance on Baidu (NASDAQ:BIDU) with significant options activity detected. Benzinga's options scanner spotted 13 uncommon options trades, with a sentiment split of 53% bullish and 30% bearish. The price range eyed by big players is between $80.0 and $165.0. Baidu's stock is currently down 1.24% at $90.28, with RSI indicators suggesting it may be oversold. An analyst from Susquehanna maintains a Positive rating with a price target of $135.

Portfolio Pulse from Benzinga Insights

June 18, 2024 | 2:45 pm

AMZN

CVS

VCR

WBA

XLY

Amazon has expanded its Prime RxPass subscription service to over 50 million Medicare beneficiaries, promising significant savings and convenience. This move could lead to a nearly $2 billion reduction in Medicare spending if all eligible beneficiaries switch to RxPass. The service aims to improve medication adherence and health outcomes, while competing with established players like CVS Health and Walgreens Boots Alliance.

Portfolio Pulse from Shivani Kumaresan

June 18, 2024 | 2:44 pm

DIS

DKNG

Dave Portnoy won nearly $1.5 million by betting on the Boston Celtics to win the NBA Championship through DraftKings. Meanwhile, rapper Drake lost $500,000 on a bet placed on the Dallas Mavericks. The Walt Disney Company benefited from high viewership of the NBA Finals and the ongoing NHL Playoffs.

Portfolio Pulse from Chris Katje

June 18, 2024 | 2:44 pm

ITCI

Intra-Cellular Therapies Inc (NASDAQ:ITCI) announced successful topline results from Study 502, evaluating lumateperone 42 mg as an adjunctive therapy for major depressive disorder (MDD). The study met its primary and key secondary endpoints, showing significant improvements in depression severity and illness severity compared to placebo. The company plans to submit a supplemental FDA application in the second half of 2024. ITCI shares rose 10.5% following the announcement.

Portfolio Pulse from Vandana Singh

June 18, 2024 | 2:37 pm

IMAX

Wanda Film is set to upgrade 61 of its top-performing locations to IMAX with Laser technology. Additionally, Wanda Film will collaborate with IMAX on new events and experiences.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 2:30 pm